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Mycoplasmas are the smallest free-living organisms and cause a number of
economically important diseases affecting humans, animals, insects, and plants. Here,
we demonstrate that highly virulent Mycoplasma mycoides subspecies capri (Mmc) can
be fully attenuated via targeted deletion of non-essential genes encoding, among others,
potential virulence traits. Five genomic regions, representing approximately 10% of the
original Mmc genome, were successively deleted using Saccharomyces cerevisiae as
an engineering platform. Specifically, a total of 68 genes out of the 432 genes verified
to be individually non-essential in the JCVI-Syn3.0 minimal cell, were excised from the
genome. In vitro characterization showed that this mutant was similar to its parental
strain in terms of its doubling time, even though 10% of the genome content were
removed. A novel in vivo challenge model in goats revealed that the wild-type parental
strain caused marked necrotizing inflammation at the site of inoculation, septicemia and
all animals reached endpoint criteria within 6 days after experimental infection. This is
in contrast to the mutant strain, which caused no clinical signs nor pathomorphological
lesions. These results highlight, for the first time, the rational design, construction and
complete attenuation of a Mycoplasma strain via synthetic genomics tools. Trait addition
using the yeast-based genome engineering platform and subsequent in vitro or in vivo
trials employing the Mycoplasma chassis will allow us to dissect the role of individual
candidate Mycoplasma virulence factors and lead the way for the development of an
attenuated designer vaccine.
Keywords: Mycoplasma mycoides subsp. capri, attenuation, genome engineering, in vivo challenge,
virulence traits
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INTRODUCTION
Bacteria belonging to the genus Mycoplasma are wall-
less bacteria that cause massive economic losses in the
livestock sector (chickens, ruminants and pigs) and
are responsible for human pneumonia and sexually
transmitted diseases (STDs). Currently, there is an absence
of commercial vaccines against infections with the human
pathogens Mycoplasma pneumoniae and Mycoplasma
genitalium (Linchevski et al., 2009). In contrast, many
livestock vaccines are commercialized, which rely either
on adjuvanted killed bacteria or on attenuated strains
obtained after successive rounds of sub-culturing or
chemical mutagenesis (Browning et al., 2005). Due to
these empirical approaches, the exact mechanism triggering
the attenuation is unknown for many of the previously
developed live attenuated Mycoplasma vaccines. Strikingly,
these vaccines are far from being optimal since they often
display short durations of immunity and limited efficacy
(Maes et al., 2008; Nicholas and Churchward, 2012; Jores
et al., 2013). A better understanding of pathogenicity
and the identification of virulence traits would foster next
generation vaccines.
For many years, the lack of genetic tools has limited
our basic understanding of Mycoplasma pathogenicity. Due
to their regressive evolution by gene loss, mycoplasmas
appear to lack many of the common bacterial effectors
and toxins used to interact with their hosts or to escape
the hosts’ immune systems (Citti et al., 2010; Chopra-
Dewasthaly et al., 2017). Lipoproteins have been proposed
to be involved in both aspects by using their cytoadherent
properties and allowing antigenic variability through phase
or sequence variation (Chambaud et al., 1999). Other
candidate virulence traits, such as the Mycoplasma Ig
binding protein-Mycoplasma Ig protease (MIB-MIP) system
(Arfi et al., 2016) and the hydrogen peroxide production
system (Blotz and Stulke, 2017) have been suggested, but not
confirmed in vivo.
The availability of a genome engineering platform that
allows directed and precise mutagenesis for Mycoplasma
mycoides is undoubtedly a new starting point toward better
understanding of host–pathogen interactions. The species
M. mycoides consists of the two subspecies M. mycoides
subsp. mycoides (Mmm) and M. mycoides subsp. capri
(Mmc), which are the causative agents of contagious bovine
pleuropneumonia and a caprine MAKePS syndrome
(comprising mastitis, arthritis, keratitis, pneumonia, and
septicemia), respectively. In this work, we engineered
a Mmc strain by deleting approximately one tenth of
the genome, including candidate virulence traits. The
resulting mutant retains almost wild-type like growth
characteristics and was attenuated both in vitro and
in vivo. The construction of this fully attenuated and safe
laboratory Mycoplasma strain paves the way for research
into host–pathogen interactions and is a good starting
point to revisit the actual role of suggested virulence
determinants in Mycoplasma.
MATERIALS AND METHODS
Mycoplasma Strains
The M. mycoides subsp. capri outbreak strain GM12 was used as
positive control in the in vivo experiment (DaMassa et al., 1983).
A modified Mycoplasma capricolum subsp. capricolum strain CK
was used as recipient strain in genome transplantation protocols
(Lartigue et al., 2009).
Yeast Strain and Media
The yeast Saccharomyces cerevisiae, strain VL6-48N (MATαhis3-
1200 trp1-11 KlURA3-11 lys2 ade2-101 met14) containing the
1.08 Mb genome of M. mycoides subsp. capri (Mmc) strain GM12
with an integrated yeast centromeric plasmid (YCp) (Lartigue
et al., 2009) was used for construction of the mutants. Yeast cells
were grown and maintained in either synthetic minimal medium
containing dextrose (SD, Takara Bio) (Lartigue et al., 2009), or
in standard rich medium containing glucose (YPD, Takara Bio)
or galactose (YPG, Takara Bio) (Noskov et al., 2010). SD medium
was supplemented with 5-fluoroorotic acid (5-FOA), for KlURA3
counter-selection (Boeke et al., 1984; Lartigue et al., 2009).
Preparation of Mutagenesis Cassettes
Sixty eight genes that encode candidate virulence traits
were seamlessly deleted from the genome of Mmc
GM12::YCpMmyc1.1 in five consecutive cycles (D1, D3,
D4, and D5) using Tandem Repeat coupled with Endonuclease
Cleavage [TREC] as described (Noskov et al., 2010; Chandran
et al., 2014) or a variation of TREC involving the Cre-lox system
for the D2 deletion, see below. Primer sequences to target and
confirm the insertion of the mutagenesis cassette into each target
site and to verify seamless deletion of the targeted genes are
shown in Supplementary Table S1.
The gts gene cluster (D2) was targeted and deleted in the
Mmc genome in the back-ground of the glpFKO deletion strain
by employing a derivative of the Mmc synthetic cell JCVI-
syn1.0 (Gibson et al., 2010). Primers RC0905 and RC0906
(Supplementary Table S1) were used to amplify the mutagenesis
cassette from the synthetic cell derivative and was targeted to
the gts region. Specific primers were used to confirm correct
insertion at the target site by amplifying the junctions between
the GM12::YCpMmyc1.1 genome and the inserted cassette.
Galactose induction resulted in the Cre-mediated deletion of the
gts region, leaving 13 bp of the 5′ end of the gtsA region, the 34 bp
loxP site, and 27 bp of the 3′ end of the lppB gene. Specific primers
were used to verify the knock-out.
Transformation and PCR Analysis
Transformation of the CORE3 cassette was performed by the
lithium acetate method as described previously (Gietz et al.,
1992). Transformed yeast were plated on appropriate selection
media [SD medium minus His (Teknova, CA) or SD medium
(minus His and minus Ura)] and incubated at 30◦C for 48 h.
Yeast colonies were patched on appropriate selective media
and total DNA was isolated for PCR screening (Noskov et al.,
2002). The correct insertion of the mutagenesis cassette was
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verified by PCR amplification using upstream and downstream
specific primers (Integrated DNA Technologies, Coralville, IA,
United States) (Supplementary Table S1).
Transplantation
The modified GM12::YCpMmyc1.1 genomes (D1–D5) were
transplanted into M. capricolum subsp. capricolum (Mcc)
recipient cells with polyethylene glycol and selected for
tetracycline resistance as described previously (Noskov et al.,
2002; Lartigue et al., 2009). The resulting mutant strains were
subjected to multiplex PCRs and pulsed-field gel electrophoresis
as described elsewhere (Labroussaa et al., 2016) to confirm
integrity of the genome.
Confirmation of the Mutants Using Next
Generation Sequencing and Mapping
Assembly
Total DNA of the strains GM12, GM12::YCpMmyc1.1 and
GM12::YCpMmyc1.1-168 was isolated as described before
(Fischer et al., 2015). DNA was sheared using sonication and
subjected to Illumina sequencing using a MiSeq machine
by University of California Santa Cruz, Santa Cruz, CA
(United States). Reads were mapped to the designed
genome sequences based on the parental strains GM12 and
GM12::YCpMmyc1.1 and GM12::YCpMmyc1.1-168. The
raw reads (300 bp PE) were QC with FastQC1. The corrected
reads were mapped onto the reference genome WT-YCP.fa
with bwa mem (Li and Durbin, 2010) and converted to sorted
bam with samtools (Li, 2011). The bam files were analyzed for
deletions using Delly2 (Rausch et al., 2012) and Sprites (Zhang
et al., 2016), and the predictions validated visually using IGV
(Thorvaldsdottir et al., 2013). The list of strains and their deleted
regions is summarized in Table 1.
Scanning Electron Microscopy of
Mycoplasma
Unless stated otherwise, chemicals were obtained from Merck
(Schaffhausen, Switzerland). Mycoplasmas were washed with
distilled water (dH2O) and fixed with 4% para-formaldehyde
(Life Technologies, Thermo Fisher, Zug, Switzerland; Cat. No.
28906) in dH2O for 5 days at 4◦C. Thereafter, samples of
40 µl of cell suspension were centrifuged onto gold-sputtered
poly-L-lysine coated coverslips (high molecular poly-L-Lysine
hydrobromide) at 125 rcf for 4 min. Coverslips were washed
once with PBS and twice with 0.1% bovine serum albumin
in PBS (BSA/PBS). Free aldehydes were blocked with 0.05 M
glycine in 0.1% BSA-c/PBS (Aurion, ANAWA Trading, Wangen,
Switzerland) for 15 min at room temperature. After 3 washes
with 0.1% BSA/PBS, cells were fixed with 2.5% glutaraldehyde
(Merck 104239) in 0.1 M cacodylate buffer (dimethylarsinic acid
sodium salt trihydrate), washed 3 times with dH2O and postfixed
with 1% OsO4 (Polysciences, Warrington, PA, United States)
in 0.1 M cacodylate buffer for 15 min. at room temperature.
Five additional washes with dH2O were followed by dehydration
1https://www.bioinformatics.babraham.ac.uk/projects/fastqc/
in an ascending ethanol series. Samples were then transferred
to hexamethyldisilazane (Merck 814051) for 10 min, air-dried,
mounted onto aluminum stubs with carbon conductive adhesive
tabs (Ted Pella Inc., Redding, CA, United States) and coated with
approximately 25 nm of gold in an SCD004 (Leica Microsystems,
Heerbrugg, Switzerland). Secondary electron micrographs and
corresponding backscattered images were obtained with a
fully digital field emission scanning electron microscope DSM
982 Gemini (Zeiss, Oberkochen, Germany) at an accelerating
voltage of 5 kV, a working distance of 6–8 mm and primary
magnifications ranging from 30,000 to 50,000×.
Growth Assay
Overnight cultures of Mycoplasma strains were grown at
37◦C in SP4 medium containing streptomycin (GM12) or
tetracycline (GM12::YCpMmyc1.1, GM12::YCpMmyc1.1-168)
for about 16 h. Doubling times of the Mycoplasma strains were
then determined as described elsewhere (Hutchison et al., 2016),
except that time interval samples were collected and processed at
0, 1, 2, 3, 4, 5, 6, 7, 9, 12, 15, and 24 h.
In vitro Hydrogen Peroxide Assay
Overnight cultures of Mycoplasma strains were grown as
described above. When the pH of overnight cultures reached 6.0–
6.5, they were inoculated into fresh SP4 medium at 1:200 dilution
and incubated at 37◦C for different time intervals of 0, 5, 7, and
24 h. At each time interval, an aliquot of culture was taken for
DNA extraction (Hutchison et al., 2016) and another aliquot was
taken to determine hydrogen peroxide levels.
To determine hydrogen peroxide levels, the aliquots were
spun at 14,000 rpm for 10 min at 4◦C. The pellets were
washed with 1 ml of cold PBS, pH 7.5 to remove traces
of media, then resuspended in 400 µl of cold PBS and
stored at 4◦C. Hydrogen peroxide levels were determined
using the Amplex Red Hydrogen Peroxide Assay Kit (Life
Technologies, NY) according to the manufacturer’s instructions.
Briefly, 50 µl of diluted samples (1:5 in PBS) was aliquoted
onto 96-well plates and warmed to 37◦C for 1 h prior to
starting the assay. 100 µM final concentration of glycerol
(Sigma-Aldrich, MO) or GPC (Sigma-Aldrich, MO) was then
added to the diluted sample and incubated at 37◦C for
1 h. 50 µl of the Amplex Red reagent was added to the
samples, incubated at room temperature in the dark for 30 min
and fluorescence was measured using a spectrophotometer
(SpectraMax M5, Molecular Devices, CA). Three technical
replicates were performed for each sample and normalized to
their respective DNA concentrations.
Detection of Immunoglobulin
Degradation by Mycoplasma in vitro and
in vivo
In vitro functionality of the MIB-MIP system was tested using the
strains GM12, GM12::YCpMmyc1.1 and GM12::YCpMmyc1.1-
168. Each strain was grown overnight at 37◦C in 3 mL modified
SP5 medium (containing 5% FBS). 250 µL of each culture was
harvested and centrifuged for 10 min at 4,000 g. The cells were
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TABLE 1 | Table showing the results of the Illumina sequencing-based mapping assemble of the strains used in this study.
Region (size in bp) YCP (9,192) D1 (2,984 bp) D2 (4,950 bp) D3 (4,677 bp) D4 (69,220 bp) D5 (24,906 bp)
GM12 Not present Present (I) Present (I) Present (I) Present (I) Present (I)
GM12::YCpMmyc1.1 (position) Present
(25,426–
34,618)
Present
(283,950–
286,934)
Present
(569,098–
574,048)
Present
(18,716–
23,393)
Present
(665,418–
734,638)
Present
(1,055,169–
1,080,075)
GM12::YCpMmyc1.1-168 Present (I) Deleted (DIS) Deleted (IS) Deleted (DIS) Deleted (DIS) Deleted (DIS)
D, detected by Delley; I, validated visually by IGV; S, detected by sprites.
then resuspended in 15 µL modified SP5 medium (containing
5% FBS) and incubated with 5 µg of purified caprine IgG
(Sigma) at 37◦C for 3 h. Bacterial CFUs were estimated for each
strain by serial dilutions and were 3.2∗109 CFUs Mmc GM12,
8.5∗108 CFUs Mmc GM12::YCpMmyc1.1, and 3.5∗108 CFUs
Mmc GM12::YCpMmyc1.1-168. A sample consisting of 5 µg
caprine IgG in dH2O was included as a control. The incubated
samples were mixed with 2× Laemmli Sample Buffer (Bio-Rad)
at a 1:1 ratio, boiled for 10 min at 98◦C and separated onto a
12% SDS-PAGE gel. They were subsequently transferred onto
a 0.2 µm nitrocellulose membrane (Bio-Rad) using a Bio-Rad
Trans-Blot R© TurboTM Transfer System (25 volts, 1.0 A, 30 min).
Next, a Western Blot was performed using PBS supplemented
with 0.1% Tween-20 and 2% BSA as a blocking buffer, and
mouse anti-goat IgG (H+L) (Jackson ImmunoResearch, 205-
005-108) and goat anti-mouse (Fc) labeled with horseradish
peroxidase (Sigma, A0168) as primary and secondary antibodies.
The antibodies were diluted in blocking buffer at 1:2000 and
1:70,000, respectively, and incubated with the membrane for
1 h each. In between the antibody incubations, the membrane
was washed once with PBS − 0.1% Tween-20 + 3.2% NaCl
and twice with PBS − 0.1% Tween-20, for 10 min each
time. The results were visualized using the Fujifilm LAS-3000
Luminescent Image Analyzer.
Serum samples derived from the in vivo challenge were diluted
in water to achieve a total load of 10–20 µg of protein per
sample. Western Blots were performed and analyzed using the
same protocol as described above.
Animal Experiment Setup
All protocols of this study were designed and performed in
strict accordance with the Kenyan and United States American
legislation for animal experimentation and were approved by the
institutional animal care and use committees at both institutions
(JCVI and ILRI, IACUC reference number 2014.08).
Sixteen male outbred goats (Capra aegagrus hircus), 1–2 years
of age and randomly selected in Naivasha, were transferred
to the ILRI campus in Nairobi and kept under quarantine
for 6 months. After arrival at the campus, all animals were
dewormed twice using levamisole and treated prophylactically
against babesiosis and anaplasmosis using imidocarb. Upon entry
to ILRI, the goats were vaccinated against anthrax and blackleg
(Blanthax R©, Cooper), Foot and Mouth Disease (FOTIVAX R©) and
Peste des Petits Ruminants (Live attenuated strain Nig. 75/1).
All animals were tested negative for presence of antibodies
against contagious caprine pleuropneumoniae (CCPP), using a
competitive ELISA (IDEXX). Two weeks before experimental
infection, all animals were transferred to the animal biosafety
level two (ABSL2) unit. Mycoplasma cells were cultivated in
PPLO medium supplemented with horse serum (Sacchini et al.,
2011) to early logarithmic phase, aliquoted and stored at
−80◦C. Afterwards, we determined the CFU using two aliquots.
Just before infection we thawed the vials and adjusted the
concentration of Mycoplasma to 109 CFU per mL−1 using broth.
All 16 goats were infected transtracheally by needle puncture 5–
10 cm distal to the larynx. Each animal received 1 mL of Mmc
GM12 or GM12::YCpMmyc1.1-168 liquid culture (equivalent
to 109 colony forming units per animal), followed by 5 mL of
phosphate buffered saline (PBS). The animals were allowed to
move freely within the ABSL2 unit and had ad libitum access
to water. They were fed ad libitum with hay and received pellets
each morning. Three veterinarians monitored the health status
of the animals throughout the experiment. Rectal temperature,
oxygen blood saturation, heart rate and breathing frequency
were measured daily in the morning hours using the GLA M750
thermometer (GLA Agricultural Electronics, United States), VE-
H100B oximeter (Edan, United States), and a stethoscope classic
II (Littmann, United States) with a water-resistant wrist watch
Seamaster (Omega, Switzerland), respectively. Blood samples for
subsequent analysis were taken twice a week by jugular vein
puncture. Goats were euthanized when they developed severe
disease associated with unwarranted moderate to severe pain.
Therefore, they received an intravenous injection of Lethabarb
Euthanasia Injection (Virbac, United States) of 200 mg.kg−1 body
weight. Severe disease and pain were determined by a fever of
≥41◦C for >3 consecutive days, an oxygen saturation of ≤92%
and a lateral recumbency of ≥1 day without the ability to feed
or intake water. Goats that were not put down because of ethical
reasons were euthanized on 28 dpi.
Pathomorphological and
Histology Analysis
A complete necropsy was performed on all animals. Tissue
samples of the neck region around the inoculation site and all
internal organs were fixed in 10% buffered formalin for 72 h and
subsequently routinely processed for paraffin embedding. Tissue
sections were cut at 3 µm and stained routinely with hematoxylin
and eosin (H&E) and evaluated by a board-certified pathologist.
Microbiology
Venous blood samples, lung samples, carpal joint fluid, and
pleural fluid specimens taken at necropsy were used for isolation
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of Mmc as described elsewhere (Liljander et al., 2015) using
Mycoplasma liquid medium (Mycoplasma Experience Ltd.,
United Kingdom). Lung samples and pleural fluid were used for
screening of Pasteurella and Mannheimia spp. using standard
methods (Carter and Cole, 1990).
Statistical Analysis
Exact and normal approximation binomial tests were used to
compare the two groups using GenStat 12th Edition (Payne
et al., 2012). P-values for differences in parameters were estimated
using a 2-sided 2-sample t-test comparing average levels between
both groups at 5% level of significance.
RESULTS
Generation of the Mutant Strain
GM12::YCpMmyc1.1-168
To demonstrate attenuation of Mmc by rational design, five
genomic regions were targeted in this study. These modifications
were done on the genome GM12::YCpMmyc1.1 cloned in
S. cerevisiae. This genome has been obtained after the insertion
of genetic elements (i.e., ARSH4, CEN6, and HIS3) in the genome
of Mmc GM12 allowing its maintenance and selection in the yeast
(Lartigue et al., 2009). The precise localizations of each deletion
are shown in Figure 1. The first two target deletion regions
FIGURE 1 | Design of mutant GM12::YCpMmyc1.1-168. Cartoon displaying the genomes of the parental strain GM12::YCpMmyc1.1 and its derivative, the deletion
mutant GM12::YCpMmyc1.1-168.
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contained genes encoding the glycerol-dependent hydrogen
peroxide metabolic pathway and its suggested ABC transporter
encoded by the gtsABCD operon (Pilo et al., 2007). This pathway
has been suggested to be a main virulence mechanism for
M. mycoides (Pilo et al., 2007), but in vivo confirmation is still
missing and in Mycoplasma gallisepticum the pathway does not
seem to be linked to virulence (Szczepanek et al., 2014). Thus,
the genes glpF, glpK, and glpO (MMCAP2_0217-0219; 2,984-bp
region; D1) and the gts gene region that includes the gene lppB
(MMCAP2_0456-0459; 4,950-bp region; D2) were deleted in the
Mmc genome by the yeast-based engineering method (Lartigue
et al., 2009). As previously mentioned, lipoproteins were another
target of interest since they likely trigger not only host–pathogen
interactions but also, overwhelming immune reactions that result
in inflammation (Browning et al., 2011). Three lipoproteins
encoded in the D3 region (MMCAP2_0014-0016; 4,677-bp) as
well as six lipoproteins in the D5 region (lppQ, MMCAP2_0889-
0904; 24,906-bp) were also excised employing again the yeast-
based engineering method. On top of that we deleted a large
genomic region that encoded the Mycoplasma-specific F1-likeX0
ATPase (Beven et al., 2012), the MIB-MIP system (Arfi et al.,
2016), an integrative and conjugative element (ICE) (Tardy et al.,
2015) and eight lipoproteins. The ICE was targeted in an effort
to reduce mobile elements from the Mmc genome. In this case,
about 70 kbp (MMCAP2_0550-0591; 69,220-bp region; D4) were
targeted and deleted from the Mmc genome using the yeast-based
engineering method in one stretch.
After each cycle of deletions, the modified Mmc genome
was isolated from yeast cells and transplanted back into
M. capricolum subsp. capricolum (Mcc) recipient cells to
confirm the viability of each mutant Mmc strain. Overall, the
final mutant strain, named Mmc GM12::YCpMmyc1.1-168,
was generated in five sequential deletion cycles (Figure 1).
The gene knock-outs were verified by amplifying across each
deleted region (Supplementary Figure S1). Genomic DNA from
the GM12::YCpMmyc1.1-168 was isolated and analyzed by
sequencing to confirm the deletions (Table 2). The genome
sequence of GM12::YCpMmyc1.1-1168 was deposited at the
ENA database under the accession number LS483503.
The Mutant Strain
GM12::YCpMmyc1.1-168 Is Viable and
Unaffected in Its Morphology or Growth
in Axenic Medium
The colonies of Mmc GM12::YCpMmyc1.1-168 were of
similar size to those of GM12::YCpMmyc1.1 and GM12.
Cell morphology of the GM12, the isogenic parental strain
GM12::YCpMmyc1.1 and GM12::YCpMmyc1.1-168 strains was
evaluated using scanning electron microscopy (Figure 2A). All
strains tested were globular in shape and lacked any special
morphological features. The diameter of the microorganisms was
in the range of 500 nm, as expected for a Mycoplasma cell.
The mutant GM12::YCpMmyc1.1-168 grew with a doubling
time somewhat similar to that of the parental strains GM12
and GM12::YCpMmyc1.1 (Figure 2B). Together, these results
strongly suggest that the deletion of approximately 100 kbp
of genomic content from the Mmc genome did not adversely
affect structural integrity or in vitro growth of the mutant
GM12::YCpMmyc1.1-168.
Inability of the Mutant Strain
GM12::YCpMmyc1.1-168 to Produce
Hydrogen Peroxide in the Presence of
Glycerol in vitro
This pathway was completely deleted in the construction
of the mutant strain GM12::YCpMmyc1.1-168. Therefore
to phenotypically confirm the deletion, we measured and
TABLE 2 | Summary of post mortem records of goats.
Animal ID. Date of
euthanasia
Bacteremia
ccu/ml
Inflammation
of the neck
around the
injection site
Pulmonary
congestion
Pulmonary
oedema
Congested
kidneys
Mucoid
enteritis and
congestion
Pleural
fluid in
thoracic
cavity
Adherent
lung to rib
cage
Liver
abscess
CK032 6 dpi 107 X X X X X X
CK034 5 dpi 107 X X X X X
CK040 5 dpi 108 X X X X X X
CK043 5 dpi 108 X X X X X
CK046 5 dpi 108 X X X X X
CK048 5 dpi 109 X X X X X
CK051 5 dpi 109 X X X X X
CL002 5 dpi 108 X X X X X X
CK035 29 dpi
CK045 28 dpi
CK047 29 dpi
CK049 28 dpi
CL001 28 dpi
CL003 28 dpi
Animals displayed in bold were infected with GM12::YCpMmyc1.1-168, the other animals were infected with GM12; dpi, days post infection; ccu, color changing unit.
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FIGURE 2 | In vitro characteristics of the parental strains GM12, GM12::YCpMmyc1.1 and its deletion mutant GM12::YCpMmyc1.1-168: (A) morphology revealed
by scanning electron microscopy. The white size bar displays 500 nm; (B) in vitro doubling time; (C) production of hydrogen peroxide in the presence of glycerol;
bars display the standard deviations in (B) and the SEM in (C).
compared hydrogen peroxide production levels between the
control GM12, GM12::YCpMmyc1.1 and GM12::YCpMmyc1.1-
168 in vitro. In the presence of the glycerol substrate,
the mutant GM12::YCpMmyc1.1-168 shows a significant
decrease in hydrogen peroxide production when compared
to its parental strains (Figure 2C). Indeed, while GM12 and
GM12::YCpMmyc1.1 produced >0.3 µM of H2O2, the mutant
strain produced very low amounts of H2O2 (0.01 µM), at least
30-fold lower under these conditions.
Inability of the Mutant Strain
GM12::YCpMmyc1.1-168 to Degrade
Immunoglobulin in vitro
Another potential virulence trait encoded by mycoplasmas is the
MIB-MIP system, which may play a role in immune evasion
by cleavage of immunoglobulins (Figure 3A) (Arfi et al., 2016).
Incubation of caprine IgG with GM12, GM12::YCpMmyc1.1
and GM12::YCpMmyc1.1-168 showed a clear difference in the
strains’ abilities to degrade IgG (Figure 3B). The two bands
at 26 and 55 kDa corresponds to the IgG light and heavy
chains. The mutant strain GM12::YCpMmyc1.1-168 exhibited
no degradation of IgG, as noted by the lack of the 44 kDa band
(Lane 3 of Figure 3B, black asterisk). This band, clearly visible
in the other two strains, is indicative of proteolytic cleavage of
the IgG heavy chain. Another pattern of degradation, with a
band at a size of about 30 kDa, is visible in the three strains. It
was previously reported that this IgG cleavage is not specific or
directly linked to the MIB-MIP system (Arfi et al., 2016).
The Mutant Strain
GM12::YCpMmyc1.1-168 Is Fully
Attenuated in vivo
We next tested whether GM12::YCpMmyc1.1-168 was able to
cause disease in its native host. Sixteen male outbred goats
(Capra aegagrus hircus) were used in this animal infection
trial. The animals were separated into two groups of equal
numbers. After the infection, no immediate clinical signs of
disease were observed. Two animals in the GM12::YCpMmyc1.1-
168 group had to be removed from the experiment, because
of acquired wounds unrelated to the infectious agent. Animal
euthanasia was planned 28 days post infection (dpi). However,
all eight animals inoculated with the GM12 strain developed
severe clinical signs, with pyrexia starting 2–3 dpi (Figure 4B).
Their body temperature continued to increase, up to 41–41.5◦C,
during the following days (Supplementary Table S2). The
animals stopped feeding, were apathetic and showed signs of
pain. According to the endpoint criteria stated in the animal
experiment protocol, they had to be euthanized between 5–6 dpi
(Figure 4A, red line). In sharp contrast, animals inoculated with
the GM12::YCpMmyc1.1-168 mutant strain did not develop any
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FIGURE 3 | In vitro and in vivo ability of the Mmc MIB-MIP system to degrade caprine IgG. (A) Cartoon displaying the proteolytic cleavage between the conserved
CH1 and the variable VH domain of the IgG heavy chain. (B) Immunoblot showing the in vitro ability of GM12 (lane 1), GM12::YCpMmyc1.1 (lane 2) to degrade IgG in
comparison to GM12::YCpMmyc1.1-168 (lane 3). (C) Immunoblot showing the in vivo IgG degradation present in serum of septicaemic goat CK51 (GM12 group)
after infection in contrast to the healthy goat CK45 (GM12::YCpMmyc1.1-168 group): 4-caprine IgG, 5-goat CK51 at –1 dpi, 6-goat CK51 at 4 dpi, 7-goat CK45 at
–1 dpi, 8-goat CK45 at 4 dpi; the black asterisk marks the 44 kDa cleaved fragment.
clinical signs of disease and were all monitored until the end of
the trial (Figure 4A). Their body temperature fluctuated within
the normal physiological range throughout the study period
(Figure 4B and Supplementary Table S2). The animals remained
healthy and gained weight during the experiment (Figure 4C).
Their heartbeat and respiratory rates, between 80–110 beats/min
and 20–30 breaths/min, respectively, remained constant over the
course of experimentation.
In all animals infected with the GM12 strain, the main
pathological lesions were similar, with a severe and extensive
inflammation of the soft tissues of the neck around the
site of inoculation. Additional macroscopic findings were
severe pulmonary edema and congestion. Histologically, there
was extensive coagulation necrosis of the connective tissue
(Figure 5B, thick arrows) and musculature surrounding the
trachea, in the vicinity of the inoculation site (Figures 5B,D,
diamonds). A marked infiltration of mainly degenerate
neutrophilic granulocytes (Figures 5B,D, asterisks) was
always found associated with the necrosis. The necrotizing
process extended to the trachea, the subcutis and skin.
In addition, all animals showed multifocal acute necrosis
with infiltration of neutrophilic granulocytes in liver and
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FIGURE 4 | Comparison of the clinical parameters monitored during the
in vivo challenge trial between the animals that received the GM12 and its
derivative GM12::YCpMmyc1.1-168. (A) Kaplan–Meier survival curve based
on animals reaching endpoint criteria. (B) Average body temperatures during
experimental infection. Values were generated using daily rectal temperatures
from the two groups. (C) Average weight gain/loss during experimental
infection. Values were generated using interval measures from the two groups.
The standard deviations are displayed as bars in (B,C).
kidney and for three animals, in the lung. These lesions
were indicative of an acute septicemia. Among all animals
infected with the mutant strain GM12::YCpMmyc1.1-168,
and upon euthanasia 28–29 dpi, no pathological lesions were
found around the inoculation site. The soft tissue around the
inoculation site was within normal limits. Additionally, neither
inflammation nor necrosis associated with the epithelium,
the submucosa or any cartilage tissues was histologically
observed (Figures 5A,C).
Mmc GM12 was re-isolated from the blood of all animals
experimentally infected with the wild-type parental strain.
Bacteremia was characterized by 106 up to 109 CCU.ml−1 of
blood, as measured by serial dilutions (Table 2). We have not
been able to re-isolate the deletion mutant from all blood samples
collected from goats infected with GM12::YCpMmyc1.1-168.
Additionally, we were not able to re-isolate the mutant strain
from tissue samples collected post mortem.
The MIB-MIP System in Mmc GM12 Is
Functional in vivo
The MIB-MIP system was shown to be active in vitro, and to
be present in large amounts at the cell surface (Krasteva et al.,
2014) during infection (Weldearegay et al., 2016). Two animal
sera were selected from the in vivo infection trial: CK51 from
the GM12 group and CK45 from the GM12::YCpMmyc1.1-168
group and tested for cleavage of IgG. The pre-infection sera from
both animals demonstrated no proteolytic cleavage of IgG when
compared to the IgG control (Figure 3C). Conversely, the post-
infection serum of CK51, which had succumbed to disease and
had a high titer of bacteria in the venous blood, clearly exhibited
the typical band at 44 kDa, consistent with the size of a cleaved
IgG heavy chain by the MIB-MIP system. As expected, no band at
44 kDa was seen in the post-infection serum of CK45. This clearly
demonstrates, for the first time, that the MIB-MIP system is
functional within the caprine host and that its proteolytic activity
is triggered during an Mmc infection.
DISCUSSION
The first aim of this work was to fully attenuate a highly
pathogenic strain of M. mycoides following a rational deletion
design. The second aim was to verify this attenuation in vivo
using the native host, since no rodent animal models for highly
virulent M. mycoides exist (Jores et al., 2013). Many candidate
virulence factors of M. mycoides have been suggested but, none
except the capsular polysaccharide (Jores et al., 2018) have
ever been confirmed according to Falkow’s postulates in vivo
(Falkow, 1988).
In order to generate an attenuated strain, we relied on previous
knowledge and selected five genomic regions that encode
candidate virulence traits. These regions, distributed around the
Mmc genome, comprised of 68 genes. The first two regions
(D1 and D2) encode enzymes and putative glycerol transporters
involved in the production of hydrogen peroxide using the
glycerol-dependent metabolism of mycoplasmas (Blotz and
Stulke, 2017). The region D3 encodes major antigens (LppA/P72)
in M. mycoides (Monnerat et al., 1999) that induced T cell
responses early in infection (Dedieu et al., 2010). The region D4
includes an integrative conjugative element (ICE), the MIB-MIP
system (Arfi et al., 2016) and the F1-likeX0 ATPase (Beven et al.,
2012). The last region (D5) encodes six lipoproteins including
the lipoprotein Q (LppQ), which has been suspected to be
involved in exacerbating immune responses and other virulence
determinants (Mulongo et al., 2015). Interestingly, among these
68 genes deleted in our mutant genome, initially comprising 944
genes and annotated RNAs, 67 were defined as non-essential
in the JCVI-Syn3.0 minimal cell, a study in which 432 genes
were classified as non-essential to sustain the life of a minimal
Mycoplasma cell only supported at the end by 438 proteins and
35 annotated RNAs (Hutchison et al., 2016). Only one gene
encoding the glycerol phosphate kinase (GlpK) (MMCAP2_0218,
region D1) was retained in the minimal JCVI-Syn3.0 cell and
classified as a “quasi-essential” gene. This means that the function
encoded by the glycerol kinase, i.e., the transfer of a phosphate
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FIGURE 5 | Composite figure displaying representative histological results from tracheal tissue at the inoculation site. Tissues were stained with hematoxylin and
eosin. (A,C) Low (40×) and high (200×) magnification of trachea of a goat inoculated with Mmc GM12::YCP1.1-168 depicting unaffected epithelium (dot),
submucosa (diamond) and cartilage (asterisk). (B,D) Low (40×) and high (200×) magnification of trachea of a goat inoculated with Mmc GM12, depicting ulceration
of the epithelium in (B) (thick arrow), massive extension of the submucosa (diamond) due to extensive areas of necrosis (arrowhead) and infiltration with large
numbers of degenerate neutrophilic granulocytes (arrow). Size standards are displayed in each picture. Scale bars: (A,B) 500 µm; (C,D) 100 µm.
group on the glycerol molecule to produce glycerol-3-phosphate,
could be compensated for by another gene which encodes a
similar function in the full-length genome. The compensatory
gene for glpK is probably absent in the minimal JCVI-Syn3.0 cell,
but present in our mutant GM12::YCpMmyc1.1-168, allowing
the deletion of glpK without any defect in growth. Therefore,
our results are consistent with the quasi-essentiality of glpK.
Altogether we retained 69 out of the 87 lipoproteins present in
GM12 by deleting 1, 3, 8, and 6 lipoproteins in D2, D3, D4,
and D5, respectively, while the minimal cell retained only 15
lipoproteins (Hutchison et al., 2016).
It was paramount for us that the mutant strain
GM12::YCpMmyc1.1-168 maintains a doubling time similar to
its parental strain, since we wanted to create a ‘K12-like’ strain
that can be further used as a cellular platform to introduce
antigen-encoding genes or large stretches of DNA. It was
interesting for us to observe that, despite complete removal of the
glycerol pathway, which may be important for cell metabolism,
there was no compelling impact on in vitro growth. It is known
that there is a trade-off between genome size and growth rate.
The drastic deletions in the genome of JCVI-syn3.0 strain led
to a substantial increase in the generation time, from ∼60 to
∼180 min (Hutchison et al., 2016). Recently, we also have shown
that the deletion of a gene encoding an enzyme important for
synthesis of carbohydrates can subsequently lead to an increase
in the generation time (Schieck et al., 2016). However, in this
work, we significantly reduced the genome of GM12 by more
than 100 kbp (i.e., 106,737 bp) without seeing any compelling
difference in the growth rate of GM12::YCpMmyc1.1-168
in comparison to the wild-type strain. Still, this reduction
represents ∼10% of the initial genome size confirming that,
in addition to the size of the deletions, the nature of the
genes deleted is also very likely to influence the generation
time of mycoplasmas.
The main goal of this work was to construct a fully attenuated
Mmc strain, that is safe to handle in the laboratory. The first
confirmation of the attenuation of the GM12::YCpMmyc1.1-
168 strain was obtained in vitro. The production of hydrogen
peroxide was almost completely abolished in the mutant
strain, confirming the participation of the glpFKO and/or
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gtsABCD pathways in the metabolism of glycerol. In addition,
the loss of the IgG specific cleavage band at 44 kDa in
GM12::YCpMmyc1.1-168 confirmed the role of the MIB-
MIP system in the degradation of the host immunoglobulins.
The mutant GM12::YCpMmyc1.1-168 is essentially a quasi-
intermediate to the minimal cell for which a high degree of
genome stability was reported. The stable reproduction of the
in vitro characteristics of GM12::YCpMmyc1.1-168 also strongly
supports stability of this mutant.
To confirm the mutant strain’s attenuation in vivo, we
developed an animal challenge model using Kenyan goats,
outbred animals derived from different herds. The use of
such animals increased variability to get a better idea of
reproducibility and significance of the results (Richter et al.,
2010). Similar challenge models using either 7.3 × 107 or
1012 CFUs of M. mycoides subsp. capri have been reported
from previous challenge experiments (Sunder et al., 2002;
Manimaran et al., 2006).
Animals infected with the GM12 strain developed specific
clinical signs (fever, heavy breathing, septicemia, etc.) and
were all euthanized by 6 dpi. Strikingly, none of the goats
infected with GM12::YCpMmyc1.1-168 developed such signs
and were healthy for the entire course of the experimentation.
These results exceeded our expectations and confirmed the
complete abolishment of pathogenicity of the mutant strain
GM12::YCpMmyc1.1-168. In addition, the massive septicemia
associated with very high titers of Mycoplasma observed in
animals infected with the GM12 strain prompted us to investigate
whether the MIB-MIP system would leave signatures of its action
on immunoglobulins (Ig) in the serum of an animal (CK51) that
had a titer of 109 CFU/ml. Specific IgG cleavage, characteristic
of the MIB-MIP system (Arfi et al., 2016), was observed. No
such cleavage was observed in the serum of animals infected
with the mutant strain. This work shows, for the first time,
that the MIB-MIP system of M. mycoides is functional in vivo.
Mycoplasmas have been viewed as stealth pathogenic organisms
because they lack most of the immune activators or PAMPs
found in other bacteria (Mogensen, 2009). Indeed, the lack of
a cell wall or the capacity to produce either LPS or flagellins
likely contribute to the chronicity of infection. The only PAMP
that has been described for several Mycoplasma species is the
surface lipoproteins, abundant components of their membrane
(Chambaud et al., 1999). In the present study, we suggest another
mechanism that could contribute to activating the immune
system. Indeed, Ig cleaved by several bacteria, including those
generated by Mycoplasma hyorhinis, have been described as
ligands of the innate immune receptor LILRA2 (Hirayasu et al.,
2016). Once bound to this receptor, it triggers the activation of
the innate immune system. It is also possible that this cleavage is
in line with the ‘nutritional virulence’ of the parasite (Abu Kwaik
and Bumann, 2013). The exact significance of the Ig cleavage
regarding Mycoplasma infection of mucosal surfaces remains to
be studied. We did not include a Sham group in our study but
recent results obtained from a transtracheal challenge of goats
with M. capricolum subsp. capripneumoniae did clearly show no
effect of Mycoplasma medium and PBS injected transtracheally as
expected (Liljander et al., 2019).
Interestingly, we observed severe inflammation around the
site of injection in the animals that received GM12 whereas
animals that were injected with the strain GM12::YCpMmyc1.1-
168 developed no such pathomorphological lesions.
Overwhelming immune reactions at the site of vaccination
have been reported from immunizations against contagious
bovine pleuropneumonia using live M. mycoides subsp. mycoides
based vaccines such as T1/44, which is the closest relative of
Mmc (Fischer et al., 2012). Therefore, it is likely that any one
or several of the deleted genes encode proteins that drive this
overwhelming immune reaction in the GM12.
To conclude, we confirmed, in vitro and in vivo, our ability to
design a fully attenuated strain via the precise reduction of∼10%
of the Mmc genome. However, we cannot currently pinpoint
the weight of each deletion on the observed attenuation. The
total clearance of the pathogen and the absence of a compelling
humoral immune response, even at the inoculation point, is
surprising and supports the total abolishment of pathogenicity.
Now it is necessary to test more defined mutants such as a glpOKF
mutant strain to get clarity about its real role in pathogenicity.
In addition, the design of next generation vaccines for, but not
restricted to, Mycoplasma diseases will benefit from this study
since a chassis that is fully attenuated and able to accommodate
antigens for vaccine delivery that can be constructed based on
our deletion mutant is now within reach. To induce a proper
immune response via such a chassis, we have the option to
add genes that appropriately stimulate an inflammatory immune
response or alternatively, we can construct different chassis that
direct responses toward Th1 or Th2 using TLR agonists. We
consider a genetically modified Mycoplasma less problematic
than other potential chassis since the survival time of Mycoplasma
in general in the environment is very short. In addition, the
unconventional codon usage (where UGA encodes tryptophan)
and high AT content of Mycoplasma minimizes the risk of spread
of genes to other bacteria. Additional experiments are necessary
to decipher the role of individual virulence traits to understand
these minimal bacterial pathogens better and to develop next
generation rationale vaccines. Regardless, this study provides an
attractive blueprint toward these goals, especially for those that
are needed in low and middle-income countries.
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